You searched for: cancer
1 to 6 of 6 results
Show
results per page
Matched phrases in profile:
MPS and cancer prognosis, circulating fDNA, Sentinel Node biopsy trials Breast Cancer Audit and cancer registries… Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?… Whole Genome Sequencing in high-risk breast cancer patients.… Breast Cancer… University of Nottingham(UK) and Mayo Clinic (USA) Chairman, Foundation for Breast Cancer Care… Background: To compare already used serum markers in advanced breast cancer, namely erythrocyte…
Breast and Endocrine Surgeon, Mater Hospitals South Brisbane.
Previous Fellowships at University of Nottingham(UK) and Mayo Clinic (USA)
Chairman, Foundation for Breast Cancer Care
Senior Surgeon Breast Screen Qld Metro south Brisbane
Breast Cancer Quality Audit - >140,000 entries , identiying gaps in service delivery to Breast Cancer patients
Matched phrases in profile:
. Survivin and XIAP have emerged as attractive targets for cancer therapeutics. This project will… Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach… Life and health after childhood cancer: a national data linkage cohort study (Cancer Australia grant led by The University of Sydney)… Blood Cancers… local, national and international collaborative research across all childhood cancer types. A/Prof… attractive small molecule targets for cancer therapeutics, with several inhibitors currently in…
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, which is part of UQ's Child Health Research Centre. The Queensland Children's Tumour Bank …
Matched phrases in profile:
Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications… Radiosensitising metastatic breast cancers by targeting DNA repair… The molecular basis of breast cancer in young women… Dr Malcolm Lim is a molecular biologist who specialises in breast cancer brain metastasis… global breast cancer mortality. This group is extremely heterogeneous and by definition exhibits…
Dr Malcolm Lim is a molecular biologist who specialises in breast cancer brain metastasis. Currently, he works in the Molecular Breast Pathology Lab with Profs Sunil Lakhani and Peter Simpson at The University of Queensland Centre for Clinical Research.
Dr Lim's research interests lies in understan …
Matched phrases in profile:
Localised immune checkpoint therapy for cutaneous head and neck cancer… but in the context of skin cancer, under the mentorship of Associate Professor James Wells. Dr…
In 2018 Dr. Amelia Soderholm was awarded a PhD in the fields of immunology and microbiology for her research under the supervision of Professor Mark Walker at the University of Queensland, Australia. Her PhD research investigated the interaction of Group A Streptococcus with innate immune signalling …
Matched phrases in profile:
Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible… Improving Treatment Efficacy by Regulating Residual Liver Cancer Self-seeding after Chemotherapy… ) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer… Background: Gynecological cancer is characterized by tumor hypoxia. However, the role of hypoxia…
Dr Haolu Wang currently is a Medical Registrar and Basic Physician Trainee with the Royal Australasian College of Physicians - The Prince Charles Hospital and Redcliffe Hospital (Northside) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer Institut …
As a translational researcher, Dr Wang has made contributions to curative efficacy evaluation in liver diseases. He real-time imaged hepatic vascular integrity and revealed the underlying molecular mechanism to predict treatment outcomes in drug-induced liver injury (Sci Rep. 2017, Theranostics. 202 …
Matched phrases in profile:
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer… , cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural… cancer. Childhood cancer is a leading cause of death and clinicians increasingly seek treatments that…
Dr Natacha Omer is a paediatic oncologist at the Queensland Children's Hospital in Brisbane. She is specialised in solid tumours, with a spacial interest in paediatric and adolescent sarcomas, cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural killer …
1 to 6 of 6 results